UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Novel Recombinant Modified Vaccinia Ankara Virus expressing Interleukin-13 Receptor α2 Antigen for Potential Cancer Immunotherapy

Current molecular medicine, 2024-01, Vol.24 (6), p.758-770

2024

Volltextzugriff (PDF)

Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma

BMC cancer, 2014-03, Vol.14 (1), p.173-173, Article 173

2014

Volltextzugriff (PDF)

Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy

Frontiers in immunology, 2022-04, Vol.13, p.878365-878365

2022

Volltextzugriff (PDF)

Novel Role of IL-13 in Fibrosis Induced by Nonalcoholic Steatohepatitis and Its Amelioration by IL-13R-Directed Cytotoxin in a Rat Model

The Journal of immunology (1950), 2008-10, Vol.181 (7), p.4656-4665

2008

Volltextzugriff (PDF)

A novel combination immunotherapy for cancer by IL-13Rα2-targeted DNA vaccine and immunotoxin in murine tumor models

The Journal of immunology (1950), 2011-11, Vol.187 (10), p.4935-4946

2011

Volltextzugriff (PDF)

Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models

Journal of translational medicine, 2010-11, Vol.8 (1), p.116-116, Article 116

2010

Volltextzugriff (PDF)

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma

Neuro-oncology (Charlottesville, Va.), 2010-08, Vol.12 (8), p.871-881

2010

Volltextzugriff (PDF)

Interleukin‐13 receptor as a unique target for anti‐glioblastoma therapy

International journal of cancer, 2001-04, Vol.92 (2), p.168-175

2001

Volltextzugriff (PDF)

IL-13 receptor-directed cancer vaccines and immunotherapy

Immunotherapy, 2012-04, Vol.4 (4), p.443-451

2012

Volltextzugriff (PDF)

The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy

Neurosurgical focus, 2006-04, Vol.20 (4), p.E11

2006

Volltextzugriff (PDF)

Convection-enhanced Delivery of Interleukin-13 Receptor-directed Cytotoxin for Malignant Glioma Therapy

Technology in cancer research & treatment, 2006-06, Vol.5 (3), p.239-250

2006

Volltextzugriff (PDF)

Immunomodulatory effects of interferons in malignancies

Journal of interferon & cytokine research, 2013-04, Vol.33 (4), p.154-161

2013

Volltextzugriff (PDF)

Interleukin-13 receptor alpha 2 chain-A potential biomarker and molecular target for ovarian cancer therapy

Cancer, 2006-09, Vol.107 (6), p.1407-1418

2006

Volltextzugriff (PDF)

A Novel Combination Immunotherapy for Cancer by IL-13R alpha 2-Targeted DNA Vaccine and Immunotoxin in Murine Tumor Models

The Journal of immunology (1950), 2011-11, Vol.187 (10), p.4935-4946

2011

Volltextzugriff (PDF)

Interleukin 13 Mediates Signal Transduction through Interleukin 13 Receptor α2 in Pancreatic Ductal Adenocarcinoma: Role of IL-13 Pseudomonas Exotoxin in Pancreatic Cancer Therapy

Clinical cancer research, 2010-01, Vol.16 (2), p.577-586

2010

Volltextzugriff (PDF)

Combination immunotherapy with IL-4 Pseudomonas exotoxin and IFN-α and IFN-γ mediate antitumor effects in vitro and in a mouse model of human ovarian cancer

Immunotherapy, 2019-04, Vol.11 (6), p.483-496

2019

Volltextzugriff (PDF)

Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway

International immunology, 1998-08, Vol.10 (8), p.1103-1110

1998

Volltextzugriff (PDF)

Current status of multipotent mesenchymal stromal cells

Tissue engineering. Part B, Reviews, 2014-06, Vol.20 (3), p.189-189

2014

Volltextzugriff (PDF)

Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside

Journal of neuro-oncology, 2003-10, Vol.65 (1), p.37

2003

Volltextzugriff (PDF)

Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors

Cancer Immunology, Immunotherapy, 2012-07, Vol.61 (7), p.1081-1092

2012

Volltextzugriff (PDF)

Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling

Journal of translational medicine, 2013-02, Vol.11 (1), p.45-45, Article 45

2013

Volltextzugriff (PDF)

Interleukin-4 cytotoxin therapy synergizes with gemcitabine in a mouse model of pancreatic ductal adenocarcinoma

Cancer research (Chicago, Ill.), 2007-10, Vol.67 (20), p.9903-9912

2007

Volltextzugriff (PDF)

Effect of Interleukin (IL)-4 Cytotoxin on Breast Tumor Growth after in Vivo Gene Transfer of IL-4 Receptor α Chain

Clinical cancer research, 2003-05, Vol.9 (5), p.1826

2003

Volltextzugriff (PDF)

Gene transfer of interleukin 13 receptor α2 chain dramatically enhances the antitumor effect of IL-13 receptor–targeted cytotoxin in human prostate cancer xenografts

Cancer gene therapy, 2001-11, Vol.8 (11), p.861-868

2001

Volltextzugriff (PDF)

IL‐13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinoma

International journal of cancer, 2009-03, Vol.124 (6), p.1440-1448

2009

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(181)

Publikationsform

Sprache

Englisch
(212)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A Novel Recombinant Modified Vaccinia Ankara Virus expressing Interleukin-13 Receptor α2 Antigen for Potential Cancer Immunotherapy

Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma

Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy

Novel Role of IL-13 in Fibrosis Induced by Nonalcoholic Steatohepatitis and Its Amelioration by IL-13R-Directed Cytotoxin in a Rat Model

A novel combination immunotherapy for cancer by IL-13Rα2-targeted DNA vaccine and immunotoxin in murine tumor models

Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma

Interleukin‐13 receptor as a unique target for anti‐glioblastoma therapy

IL-13 receptor-directed cancer vaccines and immunotherapy

The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy

Convection-enhanced Delivery of Interleukin-13 Receptor-directed Cytotoxin for Malignant Glioma Therapy

Immunomodulatory effects of interferons in malignancies

Interleukin-13 receptor alpha 2 chain-A potential biomarker and molecular target for ovarian cancer therapy

A Novel Combination Immunotherapy for Cancer by IL-13R alpha 2-Targeted DNA Vaccine and Immunotoxin in Murine Tumor Models

Interleukin 13 Mediates Signal Transduction through Interleukin 13 Receptor α2 in Pancreatic Ductal Adenocarcinoma: Role of IL-13 Pseudomonas Exotoxin in Pancreatic Cancer Therapy

Combination immunotherapy with IL-4 Pseudomonas exotoxin and IFN-α and IFN-γ mediate antitumor effects in vitro and in a mouse model of human ovarian cancer

Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway

Current status of multipotent mesenchymal stromal cells

Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside

Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors

Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling

Interleukin-4 cytotoxin therapy synergizes with gemcitabine in a mouse model of pancreatic ductal adenocarcinoma

Effect of Interleukin (IL)-4 Cytotoxin on Breast Tumor Growth after in Vivo Gene Transfer of IL-4 Receptor α Chain

Gene transfer of interleukin 13 receptor α2 chain dramatically enhances the antitumor effect of IL-13 receptor–targeted cytotoxin in human prostate cancer xenografts

IL‐13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinoma

Suchergebnisse filtern